Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of a nanomaterial bio-screening platform for neurological applications.
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
Optical Coherence Tomography for the Detection of Remote Optic Neuritis in Multiple Sclerosis.
Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.
GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.
Accelerometry as a measure of walking behavior in multiple sclerosis.
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis.
Rotating-polarization CARS microscopy: combining chemical and molecular orientation sensitivity.
The Immune Pathogenesis of Multiple Sclerosis.
The use of interferon Beta and glatiramer acetate in multiple sclerosis.
Computer-Assisted Cognitive Rehabilitation of Attention Deficits for Multiple Sclerosis: A Randomized Trial With fMRI Correlates.
Soluble CD146 in cerebrospinal fluid of active multiple sclerosis.
Three-dimensional ultra-structures of myelin and the axons in the spinal cord: Application of SEM with the osmium maceration method to the central nervous system in two mouse models.
Sex-specific environmental influences affecting MS development.
Automatic segmentation of cerebral white matter hyperintensities using only 3D FLAIR images.
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
Optimizing therapy early in multiple sclerosis: An evidence-based view.
An 8-Year-Old Boy With Ascending Paralysis.
Modulating effects of WT1 on interferon-β-vitamin D association in MS.
Modeling the Relationship among Gray Matter Atrophy, Abnormalities in Connecting White Matter, and Cognitive Performance in Early Multiple Sclerosis.
Pathological Involvement of Astrocyte-Derived Lipocalin-2 in the Demyelinating Optic Neuritis.
Pages
« first
‹ previous
…
391
392
393
394
395
396
397
398
399
…
next ›
last »